Proceedings of the 4th BEAT-PCD Conference and 5th PCD Training School.
Proceedings of the 4th BEAT-PCD Conference and 5th PCD Training School.
复制标题
DOI：
10.1186/s12919-020-00191-3
复制
发表时间：
2020-01-01
期刊：
影响因子：
--
通讯作者：
Hogg, Claire
中科院分区：
文献类型：
--
作者：
Gardner, Laura E;Horton, Katie L;Hogg, Claire
原发性睫状体运动障碍(PCD)是一种遗传性纤毛疾病，可导致慢性化脓性肺部疾病、慢性鼻窦炎、中耳疾病、亚生育和位置异常。由于PCD是罕见的，重要的是科学家和临床医生促进国际合作，分享专业知识，以便提供尽可能最佳的诊断和管理策略。“治疗原发性睫状体运动障碍的更好的实验方法”(BEAT-PCD)是一个由欧盟成本行动(BM1407)资助的多学科网络，旨在协调来自世界各地的创新基础科学和临床研究，以推动该领域的进步。第四届也是最后一届BEAT-PCD大会和第五届PCD培训学校于2019年3月在波兰波兹南联合举行。各种全会、研讨会、分组会议、口头和海报介绍的方案旨在提高代表们的知识和技能，同时也提供一个交流意见的合作平台。在这次BEAT-PCD的最后一次会议上，我们得以在成本行动的整个生命周期内制定的方案的基础上再接再厉。这些会议记录了会议的情况，突出了BEAT-PCD方案的一些成功之处。
Primary ciliary dyskinesia (PCD) is an inherited ciliopathy leading to chronic suppurative lung disease, chronic rhinosinusitis, middle ear disease, sub-fertility and situs abnormalities. As PCD is rare, it is important that scientists and clinicians foster international collaborations to share expertise in order to provide the best possible diagnostic and management strategies. 'Better Experimental Approaches to Treat Primary Ciliary Dyskinesia' (BEAT-PCD) is a multidisciplinary network funded by EU COST Action (BM1407) to coordinate innovative basic science and clinical research from across the world to drive advances in the field. The fourth and final BEAT-PCD Conference and fifth PCD Training School were held jointly in March 2019 in Poznan, Poland. The varied program of plenaries, workshops, break-out sessions, oral and poster presentations were aimed to enhance the knowledge and skills of delegates, whilst also providing a collaborative platform to exchange ideas. In this final BEAT-PCD conference we were able to build upon programmes developed throughout the lifetime of the COST Action. These proceedings report on the conference, highlighting some of the successes of the BEAT-PCD programme.